Point: Vaginal brachytherapy should be a standard adjuvant treatment for intermediate-risk endometrial cancer

Brachytherapy

Volumn 10, Issue 1, 2011, Pages 1-3

  Nout, Remi A ^a   Creutzberg, Carien L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; HYSTERECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; SALPINGOOOPHORECTOMY; VAGINAL BRACHYTHERAPY;

ADMINISTRATION, INTRAVAGINAL; BRACHYTHERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WATCHFUL WAITING;

EID: 78651468399     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2010.11.002     Document Type: Article

References (18)

1. Aalders J., Abeler V., Kolstad P., et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients. Obstet Gynecol 1980, 56:419-427.
2. Blake P., Swart A.M., Orton J., et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): Pooled trial results, systematic review, and meta-analysis. Lancet 2009, 373:137-146.
3. Creutzberg C.L., van Putten W.L., Koper P.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000, 355:1404-1411.
4. Keys H.M., Roberts J.A., Brunetto V.L., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 2004, 92:744-751.
5. Alektiar K.M., Venkatraman E., Chi D.S., et al. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys 2005, 62:111-117.
6. Anderson J.M., Stea B., Hallum A.V., et al. High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer. Int J Radiat Oncol Biol Phys 2000, 46:417-425.
7. Chadha M., Nanavati P.J., Liu P., et al. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 1999, 75:103-107.
8. Rittenberg P.V., Lotocki R.J., Heywood M.S., et al. Stage II endometrial carcinoma: Limiting post-operative radiotherapy to the vaginal vault in node-negative tumors. Gynecol Oncol 2005, 98:434-438.
9. Nout R.A., Smit T., Putter H., et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial. Lancet 2010, 375:816-823.
10. Nout R.A., Putter H., Jurgenliemk-Schulz I.M., et al. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol 2009, 27:3547-3556.
11. Creutzberg C.L., van Putten W.L., Koper P.C., et al. Survival after relapse in patients with endometrial cancer: Results from a randomized trial. Gynecol Oncol 2003, 89:201-209.
12. Pieterse A.H., Stiggelbout A.M., Baas-Thijssen M.C., et al. Benefit from preoperative radiotherapy in rectal cancer treatment: Disease-free patients' and oncologists' preferences. Br J Cancer 2007, 97:717-724.
13. Bull A.A., Meyerowitz B.E., Hart S., et al. Quality of life in women with recurrent breast cancer. Breast Cancer Res Treat 1999, 54:47-57.
14. Northouse L.L., Mood D., Kershaw T., et al. Quality of life of women with recurrent breast cancer and their family members. J Clin Oncol 2002, 20:4050-4064.
15. Heron D.E., Gerszten K., Selvaraj R.N., et al. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: A comparative dosimetric study of dose-volume histograms small star, filled. Gynecol Oncol 2003, 91:39-45.
16. Mundt A.J., Mell K., Roeske J.C. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2003, 56:1354-1360.
17. Small W., Mell L.K., Anderson P., et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys 2008, 71:428-434.
18. Kerkhof E.M., van der Put R.W., Raaymakers B.W., et al. Intrafraction motion in patients with cervical cancer: The benefit of soft tissue registration using MRI. Radiother Oncol 2009, 93:115-121.